- Home
- CGTX vs TXMD Comparison
CGTX vs TXMD Comparison
Compare CGTX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- TXMD
- Stock Information
- Founded
- CGTX 2007
- TXMD 2008
- Country
- CGTX United States
- TXMD United States
- Employees
- CGTX N/A
- TXMD N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- CGTX Health Care
- TXMD Health Care
- Exchange
- CGTX Nasdaq
- TXMD Nasdaq
- Market Cap
- CGTX 20.5M
- TXMD 17.1M
- IPO Year
- CGTX 2021
- TXMD N/A
- Fundamental
- Price
- CGTX $0.26
- TXMD $1.09
- Analyst Decision
- CGTX Strong Buy
- TXMD
- Analyst Count
- CGTX 5
- TXMD 0
- Target Price
- CGTX $5.63
- TXMD N/A
- AVG Volume (30 Days)
- CGTX 1.8M
- TXMD 66.5K
- Earning Date
- CGTX 08-07-2025
- TXMD 08-11-2025
- Dividend Yield
- CGTX N/A
- TXMD N/A
- EPS Growth
- CGTX N/A
- TXMD N/A
- EPS
- CGTX N/A
- TXMD N/A
- Revenue
- CGTX N/A
- TXMD $1,841,000.00
- Revenue This Year
- CGTX N/A
- TXMD $427.09
- Revenue Next Year
- CGTX N/A
- TXMD N/A
- P/E Ratio
- CGTX N/A
- TXMD N/A
- Revenue Growth
- CGTX N/A
- TXMD 53.55
- 52 Week Low
- CGTX $0.22
- TXMD $0.70
- 52 Week High
- CGTX $2.54
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- CGTX 37.68
- TXMD 38.09
- Support Level
- CGTX $0.29
- TXMD $1.07
- Resistance Level
- CGTX $0.32
- TXMD $1.22
- Average True Range (ATR)
- CGTX 0.03
- TXMD 0.13
- MACD
- CGTX 0.00
- TXMD -0.02
- Stochastic Oscillator
- CGTX 12.50
- TXMD 19.15
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.